QSS
KPTI icon

Quantitative Systematic Strategies’s Karyopharm Therapeutics KPTI Stock Holding History

Quantitative Systematic Strategies’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-732
Closed -$170K – 692
2020
Q4 		$170K Sell
732
-421
-37% -$97.6K 0.02% 570
2020
Q3 		$253K Buy
+1,153
New +$282K 0.04% 480
2020
Q1 		– Sell
-2,961
Closed -$851K – 403
2019
Q4 		$851K Buy
2,961
+1,161
+65% +$252K 0.13% 255
2019
Q3 		$260K Buy
+1,800
New +$244K 0.06% 359
2019
Q1 		– Sell
-719
Closed -$101K – 528
2018
Q4 		$101K Buy
+719
New +$121K 0.02% 606

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quantitative Systematic Strategies's KPTI Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Karyopharm Therapeutics (KPTI) in Q1 2021, closing a stake of 732 shares — an estimated $170K sold.

Quantitative Systematic Strategies first reported a position in KPTI in Q4 2018 and held it in 5 quarters. The position peaked at $851K in Q4 2019. 171 funds tracked by Wall St. Rank hold KPTI as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Karyopharm Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 732 Karyopharm Therapeutics shares in Q1 2021, an estimated $170K.
  • Quantitative Systematic Strategies first reported a position in Karyopharm Therapeutics in Q4 2018 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Karyopharm Therapeutics position peaked at $851K in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.